🇺🇸 FDA
Company

Atea

Atea Pharmaceuticals

AVIR pharma USA

Quick answer

Atea is a pharma company (AVIR) headquartered in BOSTON, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Bemnifosbuvir (BEM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)

Phase 3 · small_molecule · completed

1 trials project

Bemnifosbuvir-Ruzasvir

HEPATITIS C VIRUS CHRONIC INFECTION

Phase 3 · small_molecule · active

1 trials project

Bemnifosbuvir-Ruzasvir (BEM/RZR)

HEPATITIS C VIRUS CHRONIC INFECTION

Phase 3 · small_molecule · active

1 trials project

RO7496998

COVID-19

Phase 3 · small_molecule · terminated

1 trials project

AT-527

COVID-19

Phase 2 · small_molecule · terminated

2 trials project

AT-527

Hepatitis C

Phase 2 · small_molecule · completed

1 trials project

AT-752

Dengue Fever

Phase 2 · small_molecule · terminated

1 trials project

AT-777

Hepatitis C

Phase 2 · small_molecule · terminated

1 trials project

Bemnifosbuvir

Chronic Hepatitis C Virus

Phase 2 · small_molecule · completed

1 trials project

GHB11L1

Influenza, Human

Phase 2 · mab · completed

1 trials project

GHB16L2

Influenza, Human

Phase 2 · mab · completed

1 trials project

AT-527

Healthy Volunteer

Phase 1 · small_molecule · completed

1 trials project

AT-527

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-527

Chronic Hepatitis C

Phase 1 · small_molecule · completed

1 trials project

AT-527 (R07496998)

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-527 + digoxin

Healthy Volunteers Study

Phase 1 · small_molecule · completed

1 trials project

AT-527 550 mg + cyclosporine

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-527 550 mg + midazolam

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-527 Formulation 1

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-527 fasted

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials project

AT-752

Dengue

Phase 1 · small_molecule · completed

2 trials project

Bemnifosbuvir (BEM)

Healthy Volunteer

Phase 1 · small_molecule · completed

1 trials project

Bemnifosbuvir (BEM)

Healthy Volunteer Study

Phase 1 · small_molecule · completed

2 trials project

Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions

Healthy Volunteer Study

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12226429

Highly active compounds against COVID-19

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084473

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nuc

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12006340

Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12005139

Ophthalmic formulations and related methods

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11975016

2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11964047

Ophthalmic formulations and related methods

Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11833160

Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycys

Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11813278

Highly active compounds against COVID-19

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)